NIOSH R21 WTC Asthma
NCT07222501
Summary
Aim 2: Conduct a pilot RCT of SaMBA-WTC to determine feasibility and preliminary impact in preparation for a fully powered trial. (7M-24M) The investigators will conduct a pilot RCT (n=58) of the SaMBA-WTC model vs. an attention control. Data will be collected on the primary outcomes (asthma control \[asthma control test, ACT\], medication use, inhaler technique) as well as on other secondary outcomes including measures of physical function, self-management behaviors, feasibility and fidelity at baseline, at intervention completion at 3 months, and for sustainability at 6 months. This project will prepare the team for all aspects of a subsequent larger efficacy trial of SaMBA-WTC.
Eligibility
Inclusion Criteria: * Age \>=21 years; * English or Spanish speaking; * World Trade Center-certified asthma; * on asthma controller medications (as needed or standing); * uncontrolled asthma. Exclusion Criteria: * Physician's diagnosis of dementia, * COPD or other chronic pulmonary disease, * \>15 pack-years history of smoking to avoid enrolling WTC responders with undiagnosed COPD.
Conditions1
Locations1 site
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07222501